Atrioventricular junction ablation and pacemaker implant for atrial fibrillation: still a valid treatment in appropriately selected patients.
This review explores the current techniques of atrioventricular junction ablation, pacemaker prescription and implant, the role of anti-arrhythmic drugs, long-term outcomes, potential complications and adverse effects (including sudden cardiac death), and how these may be overcome, and examines the alternative strategies that are now available.
Betts
Timothy R
TR
Department of Cardiology, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK. tim.betts@orh.nhs.uk
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000503:physiopathology / Q000628:therapy*; D001283:Atrioventricular Node / Q000503:physiopathology / Q000601:surgery*; D017115:Catheter Ablation / Q000379:methods*; D004562:Electrocardiography; D006801:Humans; D010138:Pacemaker, Artificial; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents